Table 1.
Variable | BCR free survival | |
---|---|---|
HR (95%CI) | P | |
Univariate analysis | ||
Age (≤60 or >60) | 1.10 (0.64-1.90) | 0.720 |
Gleason score (≤8 or >8) | 2.70 (1.50-4.60) | <0.001*** |
Tumor Stage (T1-T2 or T3-T4) | 5.20 (2.00-13.00) | <0.001*** |
Lymph node stage (N0 or N1) | 2.00 (1.10-3.50) | 0.025* |
Distant metastasis (M0 or M1) | 0.00 (0.00-2.00) | 1.000 |
PSA (<2 or ≥2) | 9.00 (5.00-16.00) | <0.001*** |
Risk score (Low risk or High risk) | 2.30 (1.30-4.20) | 0.004** |
Multivariate analysis | ||
Gleason score (≤8 or >8) | 1.19 (0.66-2.13) | 0.568 |
Tumor Stage (T1-T2 or T3-T4) | 3.52 (1.31-9.46) | 0.013* |
Lymph node stage (N0 or N1) | 1.25 (0.68-2.29) | 0.474 |
PSA (<2 or ≥2) | 7.19 (3.96-13.04) | <0.001*** |
Risk score (Low risk or High risk) | 1.63 (0.90-2.92) | 0.105 |
*means the difference is significant at the 0.05 level ,** means the difference is significant at the 0.01 level , *** means the difference is significant at the 0.01 level.